Evaluation of the Benefit of Standard versus Extended Pelvic Lymphadenectomy at time of Radical Cystectomy for Bladder Cancer
Study Title
Evaluation of the Benefit of Standard versus Extended Pelvic Lymphadenectomy at time of Radical Cystectomy for Bladder Cancer
Purpose
To compare the effects of performing a standard lymph node removal versus an extended lymph node removal.
Eligibility
Urothelial carcinoma of the bladder that requires radical cystectomy
Plans for a cystectomy and lymph node dissection
No prior pelvic irradiation
Study Process
Patients will be randomized based on chemotherapy type, clinical stage, and performance status
Patients will be followed every 3 months for 3 years, then once a year until year 6
Trial Details
Investigator:
Alexander Gomelsky, M.D.
IRB:
Willis-Knighton
IRB Number:
14.0001
Trial Type:
Drug
Sponsor:
SWOG (southwest Oncology Group)
Contact Information:
Interested in Volunteering for the Study?
If you would like more information about this study, please call us at (318) 212-8671.